Rocket One (RKTO) Net Equity Issued and Repurchased (2019 - 2026)
Rocket One's (RKTO) quarterly Net Equity Issued and Repurchased came in at $5.1 million in Q2 2026, up 7684.42% year-over-year from $66101.0 in Q2 2025, and up 633.53% quarter-over-quarter from $701484.0 in Q1 2026.
Analysis
Rocket One (RKTO) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Rocket One has disclosed Net Equity Issued and Repurchased across 6 years of filings, most recently posting $5.1 million for Q2 2026.
- In Q2 2026, Net Equity Issued and Repurchased rose 7684.42% year-over-year to $5.1 million; the TTM figure through Jun 2026 stood at $8.5 million (up 229.22% YoY), while the FY2025 annual figure was $4.1 million, up 288.31% from the prior year.
- Net Equity Issued and Repurchased came in at $5.1 million for Q2 2026 at Rocket One, up from $701484.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $5.1 million in Q2 2026 to a low of $66101.0 in Q2 2025.
- Average Net Equity Issued and Repurchased over 4 years is $1.7 million, with a median of $1.3 million recorded in 2024.
- The largest YoY upside for Net Equity Issued and Repurchased was 7684.42% in 2026 against a maximum downside of 51.35% in 2026.
- Over 4 years, Net Equity Issued and Repurchased stood at $2.4 million in 2023, then sank by 55.89% to $1.1 million in 2024, then tumbled by 42.76% to $607309.0 in 2025, then surged by 747.28% to $5.1 million in 2026.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $5.1 million in Q2 2026, $701484.0 in Q1 2026, and $607309.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 9.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 49.20 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 5.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 Mn |
| Mar 31, 2026 | 701,484.00 |
| Dec 31, 2025 | 607,309.00 |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 66,101.00 |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2021 | -137,500.00 |
| Mar 31, 2021 | 4.57 Mn |
| Sep 30, 2019 | -1.00 |
| Jun 30, 2019 | -17,332.00 |
| Mar 31, 2019 | 5.86 Mn |